Nexium | Esomeprazole Magnesium Capsule, Delayed Release Breastfeeding
Nutrients from the food that you eat passes to your breast milk. Its good idea to take healthy diet while breastfeeding. You may need to consume more calories per day to support healthy body system. Some time it gets necessary take medicine while you are breastfeeding and as other food items passes into breast milk, medicine passes as well hence it becomes obvious to understand its effects while breastfeeding. We have analyzed many medications and in this sheet we will present some fact and known information associated with Nexium | Esomeprazole Magnesium Capsule, Delayed Release while breast-feeding.

What is Nexium | Esomeprazole Magnesium Capsule, Delayed Release used for?


NEXIUM is a proton pump inhibitor indicated for the following: Treatment of gastroesophageal reflux disease (GERD) (1.1) Risk reduction of NSAID-associated gastric ulcer (1.2) H. pylori eradication to reduce the risk of duodenal ulcer recurrence (1.3) Pathological hypersecretory conditions, including Zollinger-Ellison syndrome (1.4) 1.1 Treatment of Gastroesophageal Reflux Disease (GERD) Healing of Erosive Esophagitis NEXIUM is indicated for the short-term treatment (4 to 8 weeks) in the healing and symptomatic resolution of diagnostically confirmed erosive esophagitis. For those patients who have not healed after 4 to 8 weeks of treatment, an additional 4 to 8 week course of NEXIUM may be considered. Maintenance of Healing of Erosive Esophagitis NEXIUM is indicated to maintain symptom resolution and healing of erosive esophagitis. Controlled studies do not extend beyond 6 months. Symptomatic Gastroesophageal Reflux Disease NEXIUM is indicated for short-term treatment (4 to 8 weeks) of heartburn and other symptoms associated with GERD in adults and children 1 year or older. 1.2 Risk Reduction of NSAID-Associated Gastric Ulcer NEXIUM is indicated for the reduction in the occurrence of gastric ulcers associated with continuous NSAID therapy in patients at risk for developing gastric ulcers. Patients are considered to be at risk due to their age (≥ 60) and/or documented history of gastric ulcers. Controlled studies do not extend beyond 6 months. 1.3 H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Triple Therapy (NEXIUM plus amoxicillin and clarithromycin): NEXIUM, in combination with amoxicillin and clarithromycin, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate H. pylori Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see Clinical Studies (14) and Dosage and Administration (2)]. In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted [see Clinical Pharmacology (12.4) and the clarithromycin package insert, Clinical Pharmacology, Microbiology]. 1.4 Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome NEXIUM is indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison Syndrome.

Is Nexium | Esomeprazole Magnesium Capsule, Delayed Release safe to use while breastfeeding? Can it interfere with growth and development of my kid?

Nexium | Esomeprazole Magnesium Capsule, Delayed Release safe for breastfeeding
Esomeprazole is the only one ingredient used in manufacturing of Nexium | Esomeprazole Magnesium Capsule, Delayed Release, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Esomeprazole it is safe to use Nexium | Esomeprazole Magnesium Capsule, Delayed Release while lactating. We suggest you to check further details below about Esomeprazole usage in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Omeprazole concentrations have been measured in breast milk of one woman taking omeprazole 20 mg per day. However, the excretion of esomeprazole in milk has not been studied. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for tumorigenicity shown for NEXIUM in rat carcinogenicity studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Nexium | Esomeprazole Magnesium Capsule, Delayed Release Breastfeeding Analsys


Esomeprazole while Breastfeeding

Safe

CAS Number: 119141-88-7

S-Enantiomer of Omeprazole with which shares similar characteristics. Due to a high serum-protein-binding capacity, Omeprazole is excreted into breast milk in non-significant amount without side-effects among breastfed infants from treated mothers. Since it's neutralized by the acid pH of stomach, capsules with enteric coated granules are used. Because of this, it is thought that the small quantity of Omeprazole that may reach the breast milk would be neutralized by infant's stomach. In addition, absorption is greatly decreased by the presence of food. Esomeprazole has been used for treatment of newborn and premature infants. Hyperprolactinemia and galactorrhea have been reported by the use of Omeprazole.


Nexium | Esomeprazole Magnesium Capsule, Delayed Release Breastfeeding Analsys - 2


Esomeprazole while Breastfeeding

CAS Number: 119141-88-7

Esomeprazole is the -enantiomer of the proton-pump inhibitor, omeprazole. Limited information indicates that maternal doses of 20 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants.


Is Nexium | Esomeprazole Magnesium Capsule, Delayed Release safe while breastfeeding

I am nursing mother and I have already used Nexium | Esomeprazole Magnesium Capsule, Delayed Release, what should I do?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Nexium | Esomeprazole Magnesium Capsule, Delayed Release and have used it then do not panic as Nexium | Esomeprazole Magnesium Capsule, Delayed Release is mostly safe in breastfeeding and should not cause any harm to your baby.


My health care provider has asked me to use Nexium | Esomeprazole Magnesium Capsule, Delayed Release, what to do?

Usage of Nexium | Esomeprazole Magnesium Capsule, Delayed Release is safe for nursing mothers and baby, No worries.


If I am using Nexium | Esomeprazole Magnesium Capsule, Delayed Release, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Nexium | Esomeprazole Magnesium Capsule, Delayed Release in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients